IREN Seeks Shareholder Approval for Up to 164M Share Buyback and Reveals $552M Co-CEO Staking Grants
IREN sits 21% above its 52-week low of $28.93.
Summary
IREN's 2026 proxy seeks approval for buybacks of up to 164 million shares to offset convertible note dilution and discloses $552 million in combined Co-CEO staking grants.
Key Events · Corporate Governance and Compliance · IREN
-
Selective Buyback Approvals Sought
Proposals 2 and 3 seek shareholder approval for selective buybacks of up to 14,519,103 shares under Prepaid Forward Transactions and up to 149,899,998 shares under Capped Call Transactions, respectively.
-
Convertible Note Dilution Hedge
The buybacks would allow IREN to take delivery of shares from derivative counterparties instead of cash settlement, potentially mitigating dilution from its convertible notes.
-
Co-CEO Staking Grants Disclosed
The 2027 Co-CEO Staking Grants of 9,099,328 TRSUs to each Co-CEO carry an accounting grant date value of $275.9 million each and replace all equity incentives through Fiscal 2031.
-
Compensation Actually Paid Surges
Fiscal 2026 compensation actually paid reached approximately $506 million per Co-CEO, driven by the increase in IREN's share price from $4.66 to $45.73 over the performance period.
Analysis · IREN · Crypto Assets
IREN's definitive proxy statement for its November 24, 2026 AGM contains two significant capital-structure proposals and a major compensation disclosure. Proposals 2 and 3 seek approval for selective buybacks of up to 14.5 million shares under prepaid forward transactions and up to 149.9 million shares under capped call transactions — together representing roughly 40% of the 404.6 million ordinary shares outstanding. These buybacks, if executed, would offset dilution from IREN's convertible notes. The proxy also discloses the 2027 Co-CEO Staking Grants of 9.1 million TRSUs to each Co-CEO, valued at $275.9 million each, which replace all equity incentives through Fiscal 2031. The compensation actually paid figures of approximately $506 million per Co-CEO reflect the sharp rise in IREN's share price, not new cash outlays.
How filings like this one have moved
In the 30 days to Oct 29, 2026, 31.1% of the 1661 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IREN was trading at $34.98 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $13.7B. The 52-week trading range was $28.93 to $76.87. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.